Recap: Profound Medical Q2 Earnings

Profound Medical (NASDAQ:PROF) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Profound Medical (NASDAQ:PROF) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Profound Medical beat estimated earnings by 170.0%, reporting an EPS of $0.28 versus an estimate of $-0.4.

Revenue was down $602 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 5.02% increase in the share price the next day.

To track all earnings releases for Profound Medical visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Grown Rogue Reports Record Q1 Revenue, CEO Calls These Two States ‘Primary Growth Drivers’

Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) reported on Thursday its first-quarter 2024 results for the three months ended March 31, 2024.The Medford, Oregon-based company reported record quarterly revenue of $6.7 million, compared to $6 million in the three months ended April 30, 2023, representing a year-over-year increase of 11%."This was another exciting quarter with record revenue and aEBITDA despite the year-ago comparison period including April instead of January; April is seasonally a stronger month for the industry," Obie Strickler, CEO of Grown Rogue, said. "In addition, we achieved record indoor revenue in Michigan and Oregon during the quarter and are thrilled that an increasing number of customers in competitive markets are choosing our products which means we are continuing to bring them value."

CSE:GRIN

Read More

Earnings Preview: Usana Health Sciences

Usana Health Sciences (NYSE:USNA) is set to give its latest quarterly earnings report on Tuesday, 2022-10-25. Here's what investors need to know before the announcement. Analysts estimate that Usana Health Sciences will report an earnings per share (EPS) of $0.92.

USNA